|Articles|July 1, 2016
- Pharmaceutical Executive-07-01-2016
- Volume 36
- Issue 7
Pharmaceutical Executive, July 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Transforming Technology: The Future of the CIO in the Life Sciencesalmost 10 years ago
Keeper of the Name: Bayer's Habib Dablealmost 10 years ago
Worlds Beyond the Clinicalmost 10 years ago
'PRIME' Time for Medicines in the EUalmost 10 years ago
Pill Countersalmost 10 years ago
Country Report: Italy, Part 2Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5